Examination of the rate of peptide biosynthesis in neuroendocrine cell lines using a stable isotopic label and mass spectrometry

Journal of Neurochemistry

Volumn 90, Issue 3, 2004, Pages 585-594

  Che, Fa Yun ^a   Yuan, Quan ^a,b   Kalinina, Elena ^a   Fricker, Lloyd D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Carboxypeptidase; Gamma lipotropin; Insulin; Prohormone convertase; Proinsulin; Proopiomelanocortin

Indexed keywords

CHLOROQUINE; CONVERTASE 1; DEUTERIUM; FORSKOLIN; GAMMA LIPOTROPIN; HORMONE PRECURSOR; INSULIN; LEUCINE; LIPOTROPIN; PEPTIDE; POTASSIUM CHLORIDE; PROSERYLALANYLALANYLSERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL SECRETION; CONTROLLED STUDY; INSULIN SYNTHESIS; ISOTOPE LABELING; MASS SPECTROMETRY; MOUSE; NEUROSECRETORY CELL; NONHUMAN; PEPTIDE SYNTHESIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AMINO ACID SEQUENCE; ANIMALS; BETA-LIPOTROPIN; CELL LINE; CHLOROQUINE; CULTURE MEDIA, CONDITIONED; DEUTERIUM; FORSKOLIN; HYDROGEN-ION CONCENTRATION; INSULIN; ISLETS OF LANGERHANS; LEUCINE; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; PITUITARY GLAND; POTASSIUM CHLORIDE; RATS; STIMULATION, CHEMICAL;

ANIMALIA;

EID: 3343013767     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02522.x     Document Type: Article

References (44)

1. Antinozzi P. A., Ishihara H., Newgard C. B. and Wollheim C. B. (2002) Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell: a survey of four fuel secretagogues. J. Biol. Chem. 277, 11746-11755.
2. Asfari M., Janjic D., Meda P., Li G., Halban P. A. and Wollheim C. B. (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130, 167-178.
3. Cameron A., Fortenberry Y. and Lindberg I. (2000) The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett. 473, 135-138.
4. fat mice using differential isotopic tags and mass spectrometry. Anal Chem. 74, 3190-3198.
5. Clynen E., De Loof A. and Schoofs L. (2003) The use of peptidomics in endocrine research. Gen. Comp. Endocrinol. 132, 1-9.
6. Desiderio D. M., Wirth U., Lovelace J. L., Fridland G., Umstot E. S., Nguyen T. M., Schiller P. W., Szeto H. S. and Clapp J. F. (2000) Matrix-assisted laser desorption/ionization mass spectrometric quantification of the mu opioid receptor agonist DAMGO in ovine plasma. J. Mass Spectrom. 35, 725-733.
7. Duncan R. R., Greaves J., Wiegand U. K., Matskevich I., Bodammer G., Apps D. K., Shipston M. J. and Chow R. H. (2003) Functional and spatial segregation of secretory vesicle pools according to vesicle age. Nature 422, 176-180.
8. Eipper B. A., Perkins S. N., Husten E. J., Johnson R. C., Keutmann H. T. and Mains R. E. (1991) Peptidyl-α-hydroxyglycine α-amidating lyase: Purification, characterization, and expression. J. Biol. Chem. 266, 7827-7833.
9. Fortenberry Y., Hwang J. R., Apletalina E. V. and Lindberg I. (2002) Functional characterization of ProSAAS: similarities and differences with 7B2. J. Biol. Chem. 277, 5175-5186.
10. Fricker L. D. (1998) Carboxypeptidase E/H, in Handbook of Proteolytic Enzymes (Barrett, A., J. Rawlings, N. D. and Woessner, J. and F., eds), pp. 1341-1344. Academic Press, San Diego.
11. Fricker L. D. (2002) Carboxypeptidases E and D, in The Enzymes: Co- and Posttranslational Proteolysis of Proteins, Vol. 23 (Dalbey, R. E. and Sigman, D. S., eds), pp. 421-452. Academic Press, San Diego.
12. Fricker L. D. and Snyder S. H. (1982) Enkephalin convertase: purification and characterization of a specific enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules. Proc. Natl Acad. Sci. USA 79, 3886-3890.
13. Fricker L. D., McKinzie A. A, Sun J. et al. (2000) Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J. Neurosci. 20, 639-648.
14. Gobom J., Kraeuter K., Persson R., Steen H., Roepstorff P. and Ekman R. (2000) Detection and quantification of neurotensin in human brain tissue by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 72, 3320-3326.
15. Gold G., Gishizky M. L. and Grodsky G. M. (1982a) Evidence that glucose 'marks' beta cells resulting in preferential release of newly synthesized insulin. Science 218, 56-58.
16. Gold G., Landahl H. D., Gishizky M. L. and Grodsky G. M. (1982b) Heterogeneity and compartmental properties of insulin storage and secretion in rat islets. J. Clin. Invest. 69, 554-563.
17. Goshe M. B. and Smith R. D. (2003) Stable isotope-coded proteomic mass spectrometry. Curr. Opin. Biotechnol. 14, 101-109.
18. Greene D., Das B. and Fricker L. D. (1992) Regulation of carboxypeptidase E: effect of pH, temperature and Co++ on kinetic parameters of substrate hydrolysis. Biochem. J. 285, 613-618.
19. Gu S., Pan S., Bradbury E. M. and Chen X. (2003) Precise peptide sequencing and protein quantification in the human proteome through in vivo lysine-specific mass tagging. J. Am. Soc. Mass Spectrom. 14, 1-7.
20. Howell S. L., Parry D. G. and Taylor K. W. (1965) Secretion of newly synthesized insulin in vitro. Nature 208, 487.
21. Jimenez C. R., Li K. W., Dreisewerd K. et al. (1997) Pattern changes of pituitary peptides in rat after salt-loading as dected by means of direct, semiquantitative mass spectrometric profiling. Proc. Natl Acad. Sci. USA 94, 9481-9486.
22. Kindy J. M., Taraszka J. A., Regnier F. E. and Clemmer D. E. (2002) Quantifying peptides in isotopically labeled protease digests by ion mobility/time-of-flight mass spectrometry. Anal. Chem. 74, 950-958.
23. Krijgsveld J., Ketting R. F., Mahmoudi T., Johansen J., Artal-Sanz M., Verrijzer C. P., Plasterk R. H. and Heck A. J. (2003) Metabolic labeling of C. elegans and D. melanogaster for quantitative proteomics. Nat. Biotechnol. 21, 927-931.
24. Mains R. E. and May V. (1988) The role of a low pH intracellular compartment in the processing, storage, and secretion of ACTH and endorphin. J. Biol. Chem. 263, 7887-7894.
25. Mains R. E., Dickerson I. M., May V., Stoffers D. A., Perkins S. N., Ouafik L. H., Husten E. J. and Eipper B. A. (1990) Cellular and molecular aspects of peptide hormone biosynthesis. Front Endocrinol. 11, 52-89.
26. Moore H. P., Gumbiner B. and Kelly R. B. (1983) Chloroquin diverts ACTH from a regulated to a constitutive secretory pathway in AtT-20 cells. Nature (Lond.) 302, 434-436.
27. Noel G. and Mains R. E. (1991) The ordered secretion of bioactive peptides: oldest or newest first? Mol. Endocrinol. 5, 787-794.
28. Ong S. E., Blagoev B., Kratchmarova I., Kristensen D. B., Steen H., Pandey A. and Mann M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1, 376-386.
29. Orci L., Ravazzola M., Amherdt M., Madsen O., Perrelet A., Vassalli J. D. and Anderson R. G. (1986) Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J. Cell Biol. 103, 2273-2281.
30. Orci L., Ravazzola M., Storch M. J., Anderson R. G. W., Vassalli J. D. and Perrelet A. (1987) Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated vesicles. Cell 49, 865-868.
31. Pratt J. M., Petty J., Riba-Garcia I., Robertson D. H., Gaskell S. J., Oliver S. G. and Beynon R. J. (2002a) Dynamics of protein turnover, a missing dimension in proteomics. Mol. Cell Proteomics 1, 579-591.
32. Pratt J. M., Robertson D. H., Gaskell S. J. et al. (2002b) Stable isotope labelling in vivo as an aid to protein identification in peptide mass fingerprinting. Proteomics 2, 157-163,
33. Qian Y., Devi L. A., Mzhavia N., Munzer S., Seidah N. G. and Fricker L. D. (2000) The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J. Biol. Chem. 275, 23596-23601.
34. Sando H., Borg J. and Steiner D. F. (1972) Studies on the secretion of newly synthesized proinsulin and insulin from isolated rat islets of Langerhans. J. Clin. Invest 51, 1476-1485.
35. Schrader M. and Schulz-Knappe P. (2001) Peptidomics technologies for human body fluids. Trends Biotechnol. 19, S55-S60.
36. Seidah N. G. and Chretien M. (1998a) Prohormone Convertase 2, in Handbook of Proteolytic Enzymes (Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds), pp. 345-357. Academic Press, San Diego.
37. Seidah N. G. and Chretien M. (1998b) Proprotein Convertase I, in Handbook of Proteolytic Enzymes (Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds), pp. 349-353. Academic Press, San Diego.
38. Svensson M., Skold K., Svenningsson P. and Andren P. E. (2003) Peptidomics-based discovery of novel neuropeptides. J. Proteome Res. 2, 213-219.
39. Tanaka S., Yora T., Nakayama K., Inoue K. and Kurosumi K. (1997) Proteolytic processing of pro-opiomelanocortin occurs in acidifying secretory granules of AtT-20 cells. J. Histochem. Cytochem. 45, 425-436.
40. Tao W. A. and Aebersold R. (2003) Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr. Opin. Biotechnol. 14, 110-118.
41. Verhaert P., Uttenweiler-Joseph S., de Vries M., Loboda A., Ens W. and Standing K. G. (2001) Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: an elegant tool for peptidomics. Proteomics 1, 118-131.
42. Wei S., Feng Y., Che F.-Y., Pan H., Mzhavia N., Devi L., McKenzie A. A., Levin N., Richards W. G. and Fricker L. D. (2004) Obesity and diabetes in transgenic mice expressing proSAAS. J. Endocrinol. 180, 357-368.
43. Zhou A., Webb G., Zhu X. and Steiner D. F. (1999) Proteolytic processing in the secretory pathway. J. Biol. Chem. 274, 20745-20748.
44. Zhu H., Pan S., Gu S., Bradbury E. M. and Chen X. (2002) Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun. Mass Spectrom. 16, 2115-2123.